Advanced visualization software firm Imaging Biometrics (IB) has partnered with Arterys to bring its suite of brain tumor imaging analysis products online.
Quantitative rCBV map generated within Artery. Image courtesy of Imaging Biometrics.The nonexclusive distribution agreement allows users of the Arterys marketplace to trial and buy IB's applications for brain tumor diagnosis and treatment. IB's portfolio includes IB Neuro, an application for MR and dynamic susceptibility contrast perfusion, the IB DCE dynamic contrast-enhanced application, the Delta T1 mapping algorithm, and the IB Diffusion application.
